Navigation Links
PCMA Refutes Report from Oncologist Splinter Group on Medicare Part D
Date:2/1/2017

WASHINGTON, Feb. 1, 2017 /PRNewswire-USNewswire/ -- The Pharmaceutical Care Management Association (PCMA) issued the following statement on a new report by a splinter group of oncologists attacking the use of direct and indirect remuneration (DIR) in the popular Medicare Part D program:

"Today's attack on Medicare Part D plans' tools to reduce drug costs is a thinly veiled attempt to protect certain oncologists' profits at the expense of patients and the Medicare program itself. It's no secret they prefer Medicare Part B's fee-for-service approach, which according to MedPAC, gives providers 'incentives for use of higher priced drugs when lower priced alternatives exist.'

DIR reduces premiums for Medicare Part D beneficiaries, which leads to lower costs for the federal government. Stable and affordable premiums contribute to a 90% satisfaction rate among Part D enrollees for their drug plan.

Furthermore, the paper's dubious claim that DIR in Part D contribute to higher drug prices raises an obvious question: why are drug prices so high in Medicare Part B?

In reality, Part D plans reduce costs not only by negotiating price concessions on brand and generic drugs, but also by lowering premiums, which reduces costs for all Medicare beneficiaries as well as U.S. taxpayers."

PCMA is the national association representing America's pharmacy benefit managers (PBMs). PBMs administer prescription drug plans for more than 266 million Americans who have health insurance from a variety of sponsors including: commercial health plans, self-insured employer plans, union plans, Medicare Part D plans, the Federal Employees Health Benefits Program (FEHBP), state government employee plans, managed Medicaid plans, and others.

 

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/pcma-refutes-report-from-oncologist-splinter-group-on-medicare-part-d-300400538.html


'/>"/>
SOURCE Pharmaceutical Care Management Association
Copyright©2017 PR Newswire.
All rights reserved


Related medicine technology :

1. Global Information Online Market Research Portal Provides Complimentary Sample Service for Customers to Preview Reports by Global Industry Analysts
2. Access Pharmaceuticals Reports First Quarter Results
3. 2013 Armada Specialty Pharmacy Summit Reports Record Attendance
4. ULURU Inc. Reports First Quarter 2013 Financial Results
5. Sinovac to Host Conference Call to Report First Quarter 2013 Unaudited Financial Results
6. Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis
7. Pharmaceutical Makers and Delivery Device Partners Rethink Delivery Technologies - New Report Examines this Evolving Segment
8. Lakeland Industries to Report Fiscal Fourth Quarter and Year End Financial Results and Conduct Conference Call
9. TRACE Releases 2012 Global Enforcement Report
10. Ceregene Reports Additional Efficacy Data From Parkinsons Disease Phase 2b Study
11. LCA-Vision Reports on Annual Meeting of Stockholders
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/10/2017)... -- The Institute for In Vitro Sciences (IIVS), a ... a VITROCELL® inhalation exposure system thanks to a generous ... which is designed to replace animals in inhalation testing, ... airborne test materials in an environment that mimics the ... testing combustible tobacco products, as well as next generation ...
(Date:7/10/2017)... N.C. , July 10, 2017 Locus ... Convertible Note to support the development of CRISPR-Cas3 antimicrobial ... Holdings Limited, a leading Chinese Internet services provider, and ... will advance multiple infectious disease product programs targeting antibiotic ... Founded by Dr. Rodolphe Barrangou ...
(Date:7/5/2017)... -- Oramed Pharmaceuticals Inc. (NASDAQ: ORMP ... pharmaceutical company focused on the development of oral drug delivery ... Israel Securities Authority to dual-list its common stock on the ... trading on the TASE on July 12, 2017 under the ... Company, it is expected that Oramed will be included in ...
Breaking Medicine Technology:
(Date:7/21/2017)... (PRWEB) , ... July 21, 2017 , ... ... 4th-year medical students improve their chances of acceptance to a residency in a ... who have earned degrees outside the U.S. , According to data released by ...
(Date:7/21/2017)... ... July 21, 2017 , ... In the first prospective ACL ... Orthopaedics Outcome Network (MOON) demonstrated that patients could perform sports-related functions and maintain ... decline over time. The study, presented today at the American Orthopaedic Society ...
(Date:7/20/2017)... ... , ... ChenMed , a leading provider of value-based care for seniors, ... as Richmond Chief Medical Officer. Dr. McCarter, formerly Associate Professor of Family Medicine ... Ambulatory Services for the UVA Health System, brings 30 years of highly relevant experience ...
(Date:7/20/2017)... ... , ... For individuals with extended hospital stays or who are residents of ... are specially designed to accommodate patients with a wide range of ailments or special ... Ind., has invented the patent-pending PORTABLE ARM REST, a specially designed armrest that features ...
(Date:7/20/2017)... , ... July 20, 2017 , ... ... to the development of non-invasive devices and systems for monitoring cardiopulmonary diseases, announced ... Proceeds will be used to complete regulatory submissions and fund final engineering and ...
Breaking Medicine News(10 mins):